STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 114 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
Revenue
30
9
6
7
6
9
Revenue Growth (YoY)
-9%
0%
-25%
-13%
0%
13%
Cost of Revenue
12
3
2
3
3
3
Gross Profit
17
5
4
4
3
5
Selling, General & Admin
23
5
5
6
5
5
Research & Development
0
0
0
0
0
0
Operating Expenses
23
5
6
6
5
6
Other Non Operating Income (Expenses)
0
0
0
0
--
0
Pretax Income
-6
0
-1
-2
-2
-4
Income Tax Expense
0
0
0
0
0
0
Net Income
-6
0
-1
-2
-2
-4
Net Income Growth
-40%
-100%
-50%
--
-33%
33%
Shares Outstanding (Diluted)
5.77
5.77
4.48
4.17
4.17
4.17
Shares Change (YoY)
38%
38%
11%
19%
19%
19%
EPS (Diluted)
-1.12
0.01
-0.36
-0.59
-0.58
-1.07
EPS Growth
-54%
-101%
-31%
2,016%
-39%
-1%
Free Cash Flow
-4
0
-1
-1
0
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
56.66%
55.55%
66.66%
57.14%
50%
55.55%
Operating Margin
-20%
0%
-16.66%
-28.57%
-33.33%
0%
Profit Margin
-20%
0%
-16.66%
-28.57%
-33.33%
-44.44%
Free Cash Flow Margin
-13.33%
0%
-16.66%
-14.28%
0%
0%
EBITDA
-2
0
-1
-1
-1
0
EBITDA Margin
-6.66%
0%
-16.66%
-14.28%
-16.66%
0%
D&A For EBITDA
4
0
0
1
1
0
EBIT
-6
0
-1
-2
-2
0
EBIT Margin
-20%
0%
-16.66%
-28.57%
-33.33%
0%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are Strata Skin Sciences Inc's key financial statements?
According to the latest financial statement (Form-10K), Strata Skin Sciences Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for SSKN?
Strata Skin Sciences Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Strata Skin Sciences Inc's revenue broken down by segment or geography?
Strata Skin Sciences Inc largest revenue segment is Dermatology Recurring Procedures, at a revenue of 21,530,000 in the most earnings release.For geography, United States is the primary market for Strata Skin Sciences Inc, at a revenue of 23,028,000.
Is Strata Skin Sciences Inc profitable?
no, according to the latest financial statements, Strata Skin Sciences Inc has a net loss of $0
Does Strata Skin Sciences Inc have any liabilities?
no, Strata Skin Sciences Inc has liability of 0
How many outstanding shares for Strata Skin Sciences Inc?
Strata Skin Sciences Inc has a total outstanding shares of 0